Skip to main navigation
  • Newsroom
  • Get in Touch
  • LinkedIn
Editas Medicine logo
  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors
  • Newsroom
  • Get in Touch
  • LinkedIn

Media & Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
    • Annual Meeting Materials
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
  • Investor FAQs
  • Contact

Events & Presentations

Events & Presentations

Presentations
January 2023 Corporate Presentation
editasthumb
EDIT-301 Clinical Trial Update December 2022
EDIT-301 Clinical Trial Update December 2022 thumbnail
Past Events
Q4 2021 Editas Medicine Inc. Earnings Conference Call
Feb 24, 2022 at 8:00 AM EST
Click here for Webcast
40th Annual J.P. Morgan Healthcare Conference
Jan 12, 2022 at 10:30 AM EST
Click here for Webcast
4th Annual Evercore ISI HealthCONx Conference
Dec 2, 2021 at 9:40 AM EST
Click here for Webcast
Barclays Gene Editing & Gene Therapy Summit
Nov 15, 2021 at 8:30 AM EST
Click here for Webcast
Q3 2021 Editas Medicine Inc. Earnings Conference Call
Nov 8, 2021 at 8:00 AM EST
Click here for Webcast
Chardan 5th Annual Genetic Medicines Conference
Oct 4, 2021 at 8:30 AM EDT
Click here for Webcast
Review of BRILLIANCE Phase 1/2 Single Ascending Dose Study of EDIT-101
Sep 29, 2021 at 11:00 AM EDT

Review of BRILLIANCE Phase 1/2 Single Ascending Dose Study of EDIT-101 Presentation 2.8 MB
Click here for Webcast
Morgan Stanley 19th Annual Global Healthcare Conference
Sep 14, 2021 at 9:30 AM EDT
Click here for Webcast
Wells Fargo Healthcare Conference
Sep 10, 2021 at 8:00 AM EDT
Click here for Webcast
Q2 2021 Editas Medicine Inc. Earnings Conference Call
Aug 4, 2021 at 8:00 AM EDT
Click here for Webcast

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

>> Main navigation

  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors

©Copyright 2023 Editas Medicine

>> Footer menu

  • Get in Touch
  • Investors
  • Privacy Policy
  • Terms of Use